2B78.DE vs. 2B70.DE
2B78.DE (iShares Healthcare Innovation UCITS ETF) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds from iShares - 2B78.DE tracks the iSTOXX® FactSet Breakthrough Healthcare while 2B70.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, 2B78.DE returned -1.74%/yr vs 5.68%/yr for 2B70.DE. Their correlation of 0.85 suggests significant overlap in exposure. 2B78.DE charges 0.40%/yr vs 0.35%/yr for 2B70.DE.
Performance
2B78.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B78.DE achieves a -2.07% return, which is significantly lower than 2B70.DE's 4.53% return.
2B78.DE
- 1D
- 0.41%
- 1M
- 1.41%
- YTD
- -2.07%
- 6M
- -3.15%
- 1Y
- 14.42%
- 3Y*
- 2.27%
- 5Y*
- -1.74%
- 10Y*
- —
2B70.DE
- 1D
- 3.29%
- 1M
- 0.58%
- YTD
- 4.53%
- 6M
- 4.05%
- 1Y
- 39.50%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
2B78.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B78.DE iShares Healthcare Innovation UCITS ETF | -2.07% | 5.50% | 7.24% | -0.29% | -19.03% | 1.15% | 38.75% | 16.74% | 0.39% | 0.69% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 30.18% | -7.35% | 2.65% |
Correlation
The correlation between 2B78.DE and 2B70.DE is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.82 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.84 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2017 | 0.85 |
The correlation between 2B78.DE and 2B70.DE has been stable across timeframes, ranging from 0.82 to 0.85 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B78.DE vs. 2B70.DE — Risk / Return Rank
2B78.DE
2B70.DE
2B78.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF (2B78.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B78.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.09 | ||
| Sortino ratioReturn per unit of downside risk | -1.45 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.34 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | 6.15 | -4.92 |
| Martin ratioReturn relative to average drawdown | 3.07 | 17.06 | -13.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B78.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 2.04 | -1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | 0.28 | -0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.36 | -0.05 |
Drawdowns
2B78.DE vs. 2B70.DE - Drawdown Comparison
The maximum 2B78.DE drawdown since its inception was -38.58%, which is greater than 2B70.DE's maximum drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for 2B78.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| 2B78.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.58% | -30.87% | -7.71% |
Max Drawdown (1Y)Largest decline over 1 year | -12.05% | -6.33% | -5.72% |
Max Drawdown (3Y)Largest decline over 3 years | -25.32% | -29.34% | +4.02% |
Max Drawdown (5Y)Largest decline over 5 years | -36.99% | -30.87% | -6.12% |
Current DrawdownCurrent decline from peak | -19.03% | -1.26% | -17.77% |
Average DrawdownAverage peak-to-trough decline | -14.36% | -10.01% | -4.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.86% | 2.29% | +2.57% |
Volatility
2B78.DE vs. 2B70.DE - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF (2B78.DE) is 3.74%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 6.65%. This indicates that 2B78.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B78.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.74% | 6.65% | -2.91% |
Volatility (6M)Calculated over the trailing 6-month period | 10.97% | 14.26% | -3.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.67% | 19.09% | -3.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.91% | 20.34% | -2.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.79% | 21.76% | -2.97% |
2B78.DE vs. 2B70.DE - Expense Ratio Comparison
2B78.DE has a 0.40% expense ratio, which is higher than 2B70.DE's 0.35% expense ratio.
Dividends
2B78.DE vs. 2B70.DE - Dividend Comparison
Neither 2B78.DE nor 2B70.DE has paid dividends to shareholders.
Frequently Asked Questions
2B78.DE and 2B70.DE have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B70.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B70.DE is cheaper with a 0.35% expense ratio, compared with 0.40% for 2B78.DE.
2B78.DE tracks iSTOXX® FactSet Breakthrough Healthcare, while 2B70.DE tracks Nasdaq Biotechnology. Their fees differ too: 0.40% for 2B78.DE and 0.35% for 2B70.DE.
Find the right allocation for 2B78.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer